Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Journal of Evidence-Based Medicine
1671-5144
2015 Issue 4
Targeted Therapy : New Problems, New Exploration
WU Yi-long;SUN Yan;WANG Chang-li;LIAO Mei-lin;ZHOU Qing-hua;LU Shun;CHENG Ying;ZHOU Cai-cun;WANG Jie;ZHANG Li;CHEN Xiao-yuan;MAO Wei-min;JIANG Guo-liang;WANG Jun;WANG Qun;FENG Ji-feng;FU Xiao-long;YU Ding;HUANG Cheng;LIANG Jun;YU Shi-ying;MA Sheng-lin;YANG Jin-ji;XU Chong-rui;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:193-197
An Interview at 2015 Chinese Lung Cancer Summit Forum
YU Lin;ZHANG Hua;Editorial Department of the Journal of Evidence-Based Medicine;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:198-205
Ten Years of A Sword
WU Yi-long;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:206-207
Safety and Activity, AZD9291 and Rociletinib in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer
TU Hai-yan;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:208-209
Cumulative Incidence and Mortality of Esophageal Squamous Cell Carcinoma Declines due to One-Time Endoscopic Screening
WANG Meng;QIAO You-lin;Department of Epidemiology;Cancer Institute and Hospital;Chinese Academy of Medical Sciences;Peking Union Medical College;
..............page:210
The Present and Future of Lung Cancer Immune CheckPoint Treatment
JIANG Ben-yuan;WU Yi-long;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:211-212
Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
CHEN Xi;ZHOUJ ian-ying;LI Yang-si;Pneumology Department;The First Affiliated Hospital;Zhejiang University;
..............page:213-216
Association of PD-L1 Overexpression with Activating EGFR Mutations in Surgically Resected Non-Small Cell Lung Cancer
LIU Xiao-qing;HUANG Shu-mei;Department of Pulmonary Oncology;307 Hospital of PLA;
..............page:217-221
The Correlation between Lung Cancer Mutation Spectrum and Immune Efficacy
ZHONG Wen-zha;ZHAI Hao-ran;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;
..............page:222-224
Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer
LU Shun;YU Yong-feng;ZHANG Yi-chen;Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University;
..............page:225-227+231
Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy
XIONG Bin;DONG Zhong-yi;Department of Surgery;Zhongnan Hospital of Wuhan University;
..............page:228-231
Analysis of Serum Enzymes in Healthy Children and Adolescents by Dry Chemical System
LUO Xiao-juan;CAO Ke;MA Dong-li;LIU Xin-gang;HUANG Bao-xing;CHEN Yun-sheng;Department of Clinical Laboratory;Shenzhen Children’s Hospital;
..............page:232-236
Diagnostic Value Analysis of Serum NSE, CEA, CYFRA21-1 for Lung Cancer Based on ROC Curve and Logistic Regression
DI Yu-wei;YANG Xia;DUAN Wei;LIANG Min-wen;LI Zheng-kang;DONG Hui;Clinical Laboratory;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Pathology Department;Sun Yat-sen University Cancer Center;The First Hospital of Hebei Medical University;
..............page:237-241
Clinical Characteristics of Patients Hospitalized Again with Gastrointestinal Bleeding and Receiving Dual Antiplatelet Treatment after PCI
WANG Ling;LI Wei;LUO Jian-fang;LUO Song-yuan;CHEN Ji-yan;Department of Cardiology;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Provincial Cardiovascular Institute;
..............page:242-246+251
Introduction to Cumulative Meta-Analysis and Application of CMA Software
LI Guo-chun;The Center of Statistical Research and Consultation of TCM;Nanjing University of Chinese Medicine;
..............page:247-251
The Multimodality Therapy for Locally-Advanced Nasopharyngeal Carcinoma
YANG Li-hui;ZHENG Deng-yun;Division of Head and Neck Neoplasms;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;
..............page:252-256